AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+8.57%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.2B
AUM Growth
+$642M
(+6.1%)
Cap. Flow
-$94.3M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97
Top Buys
| 1 |
Enterprise Products Partners
EPD
|
+$60.6M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$56.7M |
| 3 |
Cheniere Energy
CQP
|
+$54.8M |
| 4 |
Western Midstream Partners
WES
|
+$47.3M |
| 5 |
Albemarle
ALB
|
+$27M |
Top Sells
| 1 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$280M |
| 2 |
Hewlett Packard
HPE
|
+$29.9M |
| 3 |
Exxon Mobil
XOM
|
+$29M |
| 4 |
Lockheed Martin
LMT
|
+$28.8M |
| 5 |
Valero Energy
VLO
|
+$27.6M |
Sector Composition
| 1 | Energy | 63.96% |
| 2 | Technology | 5.43% |
| 3 | Healthcare | 4.22% |
| 4 | Consumer Discretionary | 3.76% |
| 5 | Financials | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Travere Therapeutics
TVTX
$1.93B
| $915K | 0.01% |
43,500
+8,587
| +25% | +$181K |
|
502
Ennis
EBF
$466M
| $906K | 0.01% |
40,905
+4,155
| +11% | +$92.1K |
|
503
Keros Therapeutics
KROS
$638M
| $897K | 0.01% |
18,687
+4,665
| +33% | +$224K |
|
504
Diamond Hill
DHIL
$381M
| $897K | 0.01% |
4,846
+496
| +11% | +$91.8K |
|
505
Pinterest
PINS
$24.8B
| $895K | 0.01% |
36,865
-10,078
| -21% | -$245K |
|
506
Electronic Arts
EA
$41.5B
| $891K | 0.01% |
7,296
-1,383
| -16% | -$169K |
|
507
DocuSign
DOCU
$16B
| $884K | 0.01% |
15,947
-320
| -2% | -$17.7K |
|
508
Ralph Lauren
RL
$18.8B
| $881K | 0.01% |
8,340
+840
| +11% | +$88.8K |
|
509
Marriott International Class A Common Stock
MAR
$71.7B
| $877K | 0.01% |
5,889
-1,161
| -16% | -$173K |
|
510
Sturm, Ruger & Co
RGR
$569M
| $854K | 0.01% |
16,877
+1,707
| +11% | +$86.4K |
|
511
Brookfield
BN
$99B
| $849K | 0.01% |
26,999
-10,605
| -28% | -$334K |
|
512
ConocoPhillips
COP
$115B
| $843K | 0.01% |
7,146
-178
| -2% | -$21K |
|
513
Vericel Corp
VCEL
$1.64B
| $843K | 0.01% |
32,010
+6,247
| +24% | +$165K |
|
514
Brown-Forman Class B
BF.B
$13B
| $842K | 0.01% |
12,816
-646
| -5% | -$42.4K |
|
515
Cassava Sciences
SAVA
$105M
| $836K | 0.01% |
+28,306
| New | +$836K |
|
516
Snap
SNAP
$12.3B
| $834K | 0.01% |
93,136
-5,351
| -5% | -$47.9K |
|
517
Applovin
APP
$189B
| $825K | 0.01% |
78,362
+33,843
| +76% | +$356K |
|
|
IMGO
518
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $824K | 0.01% |
22,929
+4,556
| +25% | +$164K |
|
519
Avidity Biosciences
RNA
$6B
| $819K | 0.01% |
36,919
+8,416
| +30% | +$187K |
|
|
EQRX
520
DELISTED
EQRx, Inc. Common Stock
EQRX
| $814K | 0.01% |
331,095
+86,491
| +35% | +$213K |
|
521
Choice Hotels
CHH
$5.27B
| $802K | 0.01% |
7,118
+202
| +3% | +$22.8K |
|
522
Cogent Communications
CCOI
$1.79B
| $790K | 0.01% |
13,842
+1,442
| +12% | +$82.3K |
|
523
Morningstar
MORN
$10.9B
| $784K | 0.01% |
3,621
+374
| +12% | +$81K |
|
|
ITOS
524
DELISTED
iTeos Therapeutics
ITOS
| $775K | 0.01% |
39,697
+4,652
| +13% | +$90.9K |
|
525
Vertex Pharmaceuticals
VRTX
$102B
| $759K | 0.01% |
2,627
-120
| -4% | -$34.7K |
|